PARP-1 initiated neuronal cell death pathway–do androgens matter?

Activation of poly (ADP-ribose) polymerases contributes to ischemic damage by causing neuronal NAD + depletion, release of apoptosis-inducing factor and consequent caspase-independent cell death. PARP-mediated cell death is sexually dimorphic, participating in ischemic damage in the male brain, but not the female brain. We tested the hypothesis that androgen signaling is required for this male-specific neuronal cell death pathway. We observed smaller damage following focal cerebral ischemia (MCAO) in male PARP-1 knockout mice compared to WT as well as decreased damage in male mice treated with the PARP inhibitor PJ34. Protection from ischemic damage provided by PJ-34 in WT mice is lost after removal of testicular androgens (CAST) and rescued by androgen replacement. CAST PARP-1 KO mice exhibit increased damage compared to intact male KO mice, an effect reversed by androgen replacement in an androgen receptor-dependent manner. Lastly, we observed that ischemia causes an increase in PARP-1 expression that is diminished in the absence of testicular androgens. Our data indicates that PARP-mediated neuronal cell death in the male brain requires intact androgen-androgen receptor signaling.

[1]  Jian Cheng,et al.  Dose-Dependent Effects of Androgens on Outcome after Focal Cerebral Ischemia in Adult Male Mice , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  L. McCullough,et al.  Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke , 2009, Experimental Neurology.

[3]  P. Hurn,et al.  Sex, Sex Steroids, and Brain Injury , 2009, Seminars in reproductive medicine.

[4]  L. McCullough,et al.  Sex Differences in Minocycline-Induced Neuroprotection after Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  C. Szabó,et al.  Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. , 2008, The American journal of pathology.

[6]  P. Hurn,et al.  Gender and the Injured Brain , 2008, Anesthesia and analgesia.

[7]  L. McCullough,et al.  Pathways to ischemic neuronal cell death: are sex differences relevant? , 2008, Journal of Translational Medicine.

[8]  F. Moroni Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage. , 2008, Current opinion in pharmacology.

[9]  N. Alkayed,et al.  Deleterious Effects of Dihydrotestosterone on Cerebral Ischemic Injury , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  R. Swanson,et al.  Use of a Poly(ADP-Ribose) Polymerase Inhibitor to Suppress Inflammation and Neuronal Death After Cerebral Ischemia-Reperfusion , 2007, Stroke.

[11]  R. Swanson,et al.  Novel modulators of poly(ADP-ribose) polymerase. , 2006, Trends in pharmacological sciences.

[12]  P. Hurn,et al.  Sigma 1 Receptor Agonists Act as Neuroprotective Drugs Through Inhibition of Inducible Nitric Oxide Synthase , 2006, Anesthesia and analgesia.

[13]  Changlian Zhu,et al.  Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia–ischaemia , 2006, Journal of neurochemistry.

[14]  Michael M. Wang,et al.  Sex differences in cell death , 2005, Annals of neurology.

[15]  Csaba Szabó,et al.  Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors , 2005, Nature Reviews Drug Discovery.

[16]  L. McCullough,et al.  Ischemic Nitric Oxide and Poly (ADP-Ribose) Polymerase-1 in Cerebral Ischemia: Male Toxicity, Female Protection , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  S. Vannucci,et al.  Adult or Perinatal Brain Injury: Does Sex Matter? , 2005, Stroke.

[18]  Changlian Zhu,et al.  PARP‐1 gene disruption in mice preferentially protects males from perinatal brain injury , 2004, Journal of neurochemistry.

[19]  A. LeBlanc,et al.  Estrogen and Androgen Protection of Human Neurons against Intracellular Amyloid β1-42 Toxicity through Heat Shock Protein 70 , 2004, The Journal of Neuroscience.

[20]  V. Tomassini,et al.  Testosterone amplifies excitotoxic damage of cultured oligodendrocytes , 2004, Journal of neurochemistry.

[21]  A. LeBlanc,et al.  Testosterone‐mediated neuroprotection through the androgen receptor in human primary neurons , 2001, Journal of neurochemistry.

[22]  G. Prins,et al.  Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism , 2001, Brain Research.

[23]  P. Hurn,et al.  Estrogen as a Neuroprotectant in Stroke , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  S. Lu,et al.  Neural androgen receptor regulation: effects of androgen and antiandrogen. , 1999, Journal of neurobiology.

[25]  B. Zhivotovsky,et al.  Androgen treatment of neonatal rats decreases susceptibility of cerebellar granule neurons to oxidative stress in vitro , 1999, The European journal of neuroscience.

[26]  R. Traystman,et al.  Estrogen-mediated neuroprotection after experimental stroke in male rats. , 1998, Stroke.

[27]  A. Day,et al.  Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats , 1998, Brain Research.

[28]  S. Snyder,et al.  Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.

[29]  R. Traystman,et al.  Postischemic Brain Injury Is Affected Stereospecifically by Pentazocine in Rats , 1997, Anesthesia and analgesia.

[30]  Daniel B Hier,et al.  The Stroke Data Bank: design, methods, and baseline characteristics. , 1988, Stroke.

[31]  A. Day,et al.  Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. , 2002, Journal of applied physiology.

[32]  K. Murthy,et al.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.

[33]  V. Dawson,et al.  Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. , 2001, Stroke.

[34]  R. Traystman,et al.  Postischemic cerebral blood flow recovery in the female: effect of 17 beta-estradiol. , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.